UAE’s e& Takes Majority Stake in ‘Careem's Super App’

The Careem Super App includes renting small vehicles, digital payment, and a range of fintech services and other services. (Asharq Al-Awsat)
The Careem Super App includes renting small vehicles, digital payment, and a range of fintech services and other services. (Asharq Al-Awsat)
TT

UAE’s e& Takes Majority Stake in ‘Careem's Super App’

The Careem Super App includes renting small vehicles, digital payment, and a range of fintech services and other services. (Asharq Al-Awsat)
The Careem Super App includes renting small vehicles, digital payment, and a range of fintech services and other services. (Asharq Al-Awsat)

The UAE telecom-tech giant e& is picking up a majority stake in Careem Super App through a binding agreement with Uber Technologies.

Careem’s ride-hailing business will remain fully owned by Uber Technologies and continue to be available with all other Careem services on the existing app for customers.

e& is investing $400 million to be majority shareholder in Careem's Super App alongside Uber and all of Careem's co-founders.

The application offers around 12 services.

The Careem Super App offers food and grocery delivery, micro-mobility, a digital wallet and assorted fintech services, and other services such as home cleaning, car rental, and laundry.

Careem is operational in 10 countries across the Middle East, North Africa, and South Asia.

With the new investment, Careem plans to accelerate the realization of its ambitious vision to create the first 'everything app''. This will include expanding on the core food, grocery, and fintech services and the Careem Plus subscription program in the region while adding even more partner services to the app.

"Super apps have catalyzed the economic, social, and cultural growth of emerging markets today," said Hatem Dowidar, Group CEO of e&. "The popularity has come from the need to provide a unique and seamless customer experience."

"The mobile-first population has given rise to an ecosystem that has encouraged the use and also expanded the scope for super-apps with user expectations turned towards performing their daily activities on digital platforms."

"The Careem Super App, is a digital native that has built a rapidly growing payments, food, and grocery delivery network, and a platform for other digital businesses to scale from."

In a statement, Dara Khosrowshahi, CEO of Uber, said: "Careem helped revolutionize mobility across the greater Middle East while building an incredible brand. I am thrilled to partner with Careem, and welcome e&, as we grow the Careem super-app to deliver more services to millions of people in this fast-moving part of the world."

"All of us at Uber are excited about the impact the Careem platform will have on this region over the next decade and beyond."

Completion of the transaction remains subject to regulatory approvals, customary closing conditions, and administrative procedures.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.